Guidelines for Evaluating an Essential Drugs Programme
(64 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoINTRODUCTION
Ver el documentoPROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
Ver el documentoEXECUTIVE SUMMARY: OVERALL CONCLUSIONS AND RECOMMENDATIONS
Ver el documento1. SUMMARY BACKGROUND INFORMATION ON COUNTRY AND HEALTH CARE SYSTEM1
Ver el documento2. BRIEF DESCRIPTION OF THE GENERAL FEATURES OF THE APED PROGRAMME
Ver el documento3. ECONOMIC AND SOCIOECONOMIC ASPECTS OF THE APED PROGRAMME
Cerrar esta carpeta4. ANALYSIS OF EFFICIENCY
Abrir esta carpeta y ver su contenido4.1 SELECTION
Cerrar esta carpeta4.2 LOGISTICS
Cerrar esta carpeta4.2.1 PROCUREMENT
Ver el documentoA. PROCUREMENT METHOD
Ver el documentoB. CONTRACT TERMS
Ver el documentoC. LOCATING AND SELECTING SUPPLIERS
Ver el documentoD. PROCURING
Ver el documentoE. MONITORING SUPPLIER PERFORMANCE
Ver el documentoF. QUALITY ASSURANCE
Ver el documentoG. LOCAL PRODUCTION OF PHARMACEUTICALS OR IMPORT
Abrir esta carpeta y ver su contenido4.2.2 DISTRIBUTION
Abrir esta carpeta y ver su contenido4.2.3 LOGISTIC SUPPORT
Abrir esta carpeta y ver su contenido4.3 MANPOWER DEVELOPMENT
Ver el documento4.4 HEALTH EDUCATION AND INFORMATION
Abrir esta carpeta y ver su contenido4.5 POLICY AND LEGAL ASPECTS
Abrir esta carpeta y ver su contenido5. ASSESSMENT OF EFFECTIVENESS
Abrir esta carpeta y ver su contenido6. MANAGING THE ESSENTIAL DRUG PROGRAMME
Abrir esta carpeta y ver su contenido7. ASSESSMENT OF INPUTS OF THE GOVERNMENT AND DONORS
Abrir esta carpeta y ver su contenido8. PLANNING FOR THE FUTURE
Ver el documento9. REFERENCES
Abrir esta carpeta y ver su contenidoMANUAL FOR CONDUCTING AN EVALUATION OF AIM ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
 
G. LOCAL PRODUCTION OF PHARMACEUTICALS OR IMPORT

a) Describe the local pharmaceutical production capability doing:

- primary manufacturing (the production of active medicinal substances and other ancillary substances used in pharmaceutical formulations);

- secondary manufacturing (the processing of medicinal substances, usually together with ancillary substances, to produce the required pharmaceutical dosage forms);

- packaging (the packaging of dosage forms in manners appropriate to the nature of the preparations and their intended use, conditions of transportation, and expected conditions and time of storage).


and assess the potential for the future (Does government policy promote local production?).

b) Are locally-produced drugs essential?

c) Assess whether locally-produced drugs are competitive with similar drugs on the international market?

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013